CLASS II Drug recall · Reported 15 Apr 2020 · FDA Enforcement Report

Testosterone Cypionate In Sesame Oil 200mg/ml, Injectable recalled

Innovative Intrathecal Solutions is recalling Testosterone Cypionate In Sesame Oil 200mg/ml, Injectable, distributed in California, Maine, Texas. The recall was initiated on 26 Mar 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 11152019@41,Expires after 04-07-2020; Lot # 12042019@12, Expires after 04-26-2020; Lot # 12172019@9, Expires after 05-09-2020; Lot # 01032020@49, Expires after 05-26-2020; Lot # 01162020@55, Expires after 06-08-2020
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1098-2020
FDA event ID
85351
Recalling firm
Innovative Intrathecal Solutions, Murrieta, CA
Classification
Class II
Status
Terminated
Recall initiated
26 Mar 2020
FDA classified
6 Apr 2020
Reported
15 Apr 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

26 Mar 2020Recall initiated by company
6 Apr 2020Classified by FDA+11 days
15 Apr 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Testosterone Cypionate In Sesame Oil 200mg/ml, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562 951-304-9530

Where it was distributed

Patient Distribution list includes addresses in the following states: CA, ME, TX

CaliforniaMaineTexas

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot #: 11152019@41,Expires after 04-07-2020; Lot # 12042019@12, Expires after 04-26-2020; Lot # 12172019@9, Expires after 05-09-2020; Lot # 01032020@49, Expires after 05-26-2020; Lot # 01162020@55, Expires after 06-08-2020

Where was it sold?

Patient Distribution list includes addresses in the following states: CA, ME, TX

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 85351

More recalls from Innovative Intrathecal Solutions

All 5

Other Testosterone Cypionate recalls

All 130